FDA Approves First Biologic Treatment for Polymyalgia Rheumatica ...Middle East

The interleukin-6 receptor antagonist sarilumab (Kevzara) will be indicated in adults who have had an inadequate response to corticosteroids or could not tolerate a corticosteroid taper. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Biologic Treatment for Polymyalgia Rheumatica )

Also on site :

• Christina Aguilera, 44, Wears Nothing But Leather Lingerie in Racy Photos
• 'Law & Order' Star, 64, Suffers Heartbreaking Family Loss
• Iconic ’70s Rock Band Reuniting for First Performance in Over a Decade